Literature DB >> 1671582

Enhanced aspartate release from hippocampal slices of epileptic (El) mice.

H J Flavin1, A Wieraszko, T N Seyfried.   

Abstract

The release of putative neurotransmitters [aspartate, glutamate, and gamma-aminobutyric acid (GABA)] was studied in hippocampal slices from adult normal C57BL/6J (B6) and El (epileptic) mice. The El mice, a genetic model of temporal lobe epilepsy, had an average of 86 seizures. Sets of B6 and El hippocampal slices (400 microns thick) were incubated in a series of normal and high potassium (60 mM) buffers in the presence or absence of calcium. The calcium-dependent and calcium-independent potassium-induced release of amino acids was compared in each mouse strain. Release of endogenous amino acids was measured using liquid chromatography with electrochemical detection and was expressed as picomoles of amino acid released per milliliter of incubation buffer per minute of incubation per slice +/- SEM. No significant differences were found between the El and B6 mice for the calcium-dependent potassium-evoked release of glutamate (18.20 +/- 2.62 and 15.41 +/- 3.56), or GABA (17.28 +/- 2.90 and 12.73 +/- 1.37), respectively. Aspartate release, however, was significantly higher in the El mice (6.62 +/- 0.69) than in the B6 mice (3.31 +/- 0.72). These findings suggest that enhanced aspartate release may be related to seizure expression in El mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671582     DOI: 10.1111/j.1471-4159.1991.tb02021.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  A major effect QTL determined by multiple genes in epileptic EL mice.

Authors:  M E Legare; F S Bartlett; W N Frankel
Journal:  Genome Res       Date:  2000-01       Impact factor: 9.043

2.  Congenic strains reveal effects of the epilepsy quantitative trait locus, El2, separate from other El loci.

Authors:  W N Frankel; E W Johnson; C M Lutz
Journal:  Mamm Genome       Date:  1995-12       Impact factor: 2.957

3.  Increased Hippocampal Afterdischarge Threshold in Ketogenic Diet is Accompanied by Enhanced Kynurenine Pathway Activity.

Authors:  Bartosz Osuch; Karolina Kołosowska; Natalia Chmielewska; Danuta Turzyńska; Alicja Sobolewska; Janusz Szyndler; Piotr Maciejak
Journal:  Neurochem Res       Date:  2022-05-06       Impact factor: 3.996

4.  Genetic epilepsy model derived from common inbred mouse strains.

Authors:  W N Frankel; B A Taylor; J L Noebels; C M Lutz
Journal:  Genetics       Date:  1994-10       Impact factor: 4.562

5.  Long lasting effects of audiogenic seizures on synaptosomal neurotransmitter amino acids in Rb mice.

Authors:  S Simler; L Ciesielski; J Clement; A Rastegar; P Mandel
Journal:  Neurochem Res       Date:  1994-05       Impact factor: 3.996

6.  Altered GABAergic and glutamatergic transmission in audiogenic seizure-susceptible mice.

Authors:  M L Cordero; J G Ortiz; G Santiago; A Negrón; J A Moreira
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

7.  Influence of caloric restriction on constitutive expression of NF-κB in an experimental mouse astrocytoma.

Authors:  Tiernan J Mulrooney; Jeremy Marsh; Ivan Urits; Thomas N Seyfried; Purna Mukherjee
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

8.  Dietary restriction promotes vessel maturation in a mouse astrocytoma.

Authors:  Ivan Urits; Purna Mukherjee; Joshua Meidenbauer; Thomas N Seyfried
Journal:  J Oncol       Date:  2011-12-27       Impact factor: 4.375

9.  Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model.

Authors:  P Mukherjee; M M El-Abbadi; J L Kasperzyk; M K Ranes; T N Seyfried
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

10.  Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet.

Authors:  Jeremy Marsh; Purna Mukherjee; Thomas N Seyfried
Journal:  Nutr Metab (Lond)       Date:  2008-11-25       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.